Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options

[Sponsored] FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease. The post Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options appeared first on MedCity News.

Read More

Can Someone Actually Be Responsible?

By MATTHEW HOLT I was having a fight on Twitter this week and it hit me. America 2024 is Japan 1989.  The topic of the fight was right-wing VC Peter Thiel. In 2001 he put a ton of Paypal stock allegedly worth less than $2,000 into a Roth IRA. The Roth IRA was designed so…

Read More

Silence in Sikeston: Is There a Cure for Racism?

SIKESTON, Mo. — In the summer of 2021, Sikeston residents organized the biggest Juneteenth party in the city’s history. Sikeston police officers came too, both to provide security for the event and to try to build bridges with the community. But after decades of mistrust, some residents questioned their motives.  In the series finale of…

Read More